Phase II Trial of Continuation Therapy in Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Alvimopan Use in Polytraumatized Patients
- Status
- TERMINATED
- Phase
- PHASE4
A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604)
- Status
- COMPLETED
- Phase
- PHASE3
89Zr-labeled Pembrolizumab in Patients With Non-small-cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Intralesional Administration of MK-4621 (RGT100) in Adult Participants With Advanced or Recurrent Tumors (MK-4621-001/RGT100-001)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Pembrolizumab (MK-3475) or Placebo Given With Best Supportive Care in Asian Participants With Previously Treated Advanced Hepatocellular Carcinoma (MK-3475-394/KEYNOTE-394)
- Status
- COMPLETED
- Phase
- PHASE3
Assessing Ovarian Function During Prolonged Implant Use
- Status
- COMPLETED
- Phase
- N/A
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab for Sarcoma
- Status
- COMPLETED
- Phase
- PHASE2
An Active-Controlled Early Phase Study of Elpipodect (MK-8189) in Adults With Schizophrenia (MK-8189-005)
- Status
- COMPLETED
- Phase
- PHASE2
Phase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BC
- Status
- TERMINATED
- Phase
- PHASE2
A Randomized Phase II Study Of Eribulin Mesylate With or Without Pembrolizumab For Metastatic Hormone Receptor Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab and Capecitabine in Treating Patients With Locally Advanced or Metastatic Triple Negative or Hormone-Refractory Breast Cancer That Cannot Be Removed by Surgery
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Pembrolizumab With Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Grazoprevir and Elbasvir for GT1ang GT6 With and Without HIV
- Status
- UNKNOWN
- Phase
- PHASE4
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522)
- Status
- COMPLETED
- Phase
- PHASE3